Impeded cerebellar development and reduced serum thyroxine levels associated with fetal alcohol intoxication.
Pregnant albino rats were placed on a complete liquid diet (Ensure) containing either 9% ethanol or an isocaloric amount of sucrose between the third and twentieth day of gestation. The pups born to these rats were sacrificed either day 11 or day 14 postnatum and morphometrical, histological and biochemical analyses were done on their cerebellums and cerebrums. Pups that were exposed to ethanol in utero had significantly smaller body weights, cerebrums and cerebellums than pair-fed controls. The cerebellar mass was reduced by 10% and the cerebral weight by 3% in the pups exposed to alcohol when body weights were normalized to that of pair-fed controls. Cerebellar aspartyl aminotransferase (EC 2.6.1.1) activity was reduced at day 11 and 14 in ethanol treated pups compared with controls. Serum T4 levels were also reduced in the ethanol treated group. Histological analyses revealed that the external granule cell (EGC) layer of ethanol treated pups was significantly thicker at 11 and 14 days postnatum than that of pair-fed control pups. Cerebellar ornithine decarboxylase (ODC, EC 4.1.1.17) activity was higher at day 11 in the ethanol treated pups than in controls. The reduced mass, AAT activity, T4 serum levels and the increased thickness of the ECG layer indicate a delayed or impeded maturation of cerebellum in ethanol treated pups. These data are considered from the viewpoint that ethanol, other drugs such as methadone and prenatal stress (malnutrition) may cause delayed cerebellar maturation by reducing serum T4 levels in the early postnatal period (day 5-14).
D000428:Alcohol Drinking; D000818:Animals; D001219:Aspartate Aminotransferases / Q000378:metabolism; D001835:Body Weight / Q000187:drug effects; D002525:Cerebellar Cortex / Q000187:drug effects* / Q000201:enzymology / Q000254:growth & development; D002540:Cerebral Cortex / Q000187:drug effects / Q000201:enzymology / Q000254:growth & development; D005260:Female; D063647:Fetal Alcohol Spectrum Disorders / Q000097:blood*; D008291:Malate Dehydrogenase / Q000378:metabolism; D009929:Organ Size / Q000187:drug effects; D009955:Ornithine Decarboxylase / Q000378:metabolism; D011247:Pregnancy; D051381:Rats; D013974:Thyroxine / Q000097:blood*
D008291:Malate Dehydrogenase; D001219:Aspartate Aminotransferases; D009955:Ornithine Decarboxylase; D013974:Thyroxine